Budget 2026 Focuses on Biopharma, Diagnostics to Cut Healthcare Costs For Middle Class National Dr Jitendra Singh says Budget 2026's push for affordable drugs and vaccines via biomanufacturing will ease healthcare costs for the middle class.
Powell's Final Fed Decision: Rates Held as Global Uncertainty and Inflation Dominate Policy Outlook International